Download PDF
Hamostaseologie 1984; 04(04): 118-122
DOI: 10.1055/s-0038-1659934
Originaler Artikel
Schattauer GmbH

Die Bedeutung der Thrombozyten bei der Entstehung und Persistenz der Glomerulonephritis

J. S. Cameron
1   Guy’s Hospital, London, U.K.
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Zamonbi L. Anatomy and embryology of the kidney, ureter, bladder and urethra. In: Massry S.G, Glassock R.J. (Eds.) Textbook of Nephrology. Williams & Wilkins; Baltimore: 1982: 1.3-1.27.
    Google Scholar
  • 2 Nackman R.L, Weksler B.B. The platelet as in inflammatory cell. In: Weissman G. (Ed.) Cell Biology and Inflammation. Elsevier; Amsterdam: 1980: 145-162.
    Google Scholar
  • 3 Zimmerman T.S, Fierer J, RoArbergen H. Blood coagulation and the inflammatory response. Semin. Hematol. 14: 391-408 1977;
    PubMedGoogle Scholar
  • 4 Holmsen H, Salganicoff L, Fukomi H. Platelet behaviour and biochemistry. In: Ogston D, Bennett B. (Eds.) Haemostasis, Physiology and Pathology. Wiley; New York: 1973: 241-319.
    Google Scholar
  • 5 Heldin C-H, Westermark B, Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem. J. 193: 907-913 1981;
    CrossrefPubMedGoogle Scholar
  • 6 Nakashima Y, Hirose S, Hamashima Y. Proliferation of cultured rabbit renal glomerular cells stimulated by platelet factor. Acta Pathol. Jpn. 30: 1-7 1980;
    PubMedGoogle Scholar
  • 7 Deuel T.F, Senior R.M, Chang D, Griffin G.L, Henrikson R.L, Kaiser E.T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. U.S.A. 78: 4584-4587 1981;
    CrossrefPubMedGoogle Scholar
  • 8 Deuel T.F, Senior R.M, Huang J.S. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 66: 1046-1049 1982;
    PubMedGoogle Scholar
  • 9 Dunn M.J. The role of arachidonic acid metabolites in glomerulonephritis. In: Remuzzi G, Bertani T. (Eds.) Glomerular Injury 300 Years After Morgagni. T. Wichtig; Milan: 1983
    Google Scholar
  • 10 Polley M.J, Nachman R. The human complement system in thrombin-mediated platelet function. J. Exp. Med. 147: 1713-1726 1978;
    CrossrefPubMedGoogle Scholar
  • 11 Humphrey J.H, Jaques R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J. Physiol. 128: 9-17 1955;
    CrossrefPubMedGoogle Scholar
  • 12 Henson P.M, Spiegelberg H.L. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and sub-classes. J. Clin. Invest. 52: 1282-1288 1973;
    CrossrefPubMedGoogle Scholar
  • 13 Clark W.E, Teraarwerk G.M, Bandali K, Lindsay R.M, Linton A.L. Platelet aggregation and release associated with immune complex formation in pig plasma. J. Lab. Clin. Med. 90: 654-665 1980;
    PubMedGoogle Scholar
  • 14 Benveniste J, Henson P.M, Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. J. Exp. Med. 136: 1356-1377 1972;
    CrossrefPubMedGoogle Scholar
  • 15 Benveniste J, Jouvin E, Pirotzky E, Arnoux B, Mencia-Huerta J.M, Roubin R, Vargaftig B.B. Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions. Int. Arch. Allerg. Appl. Immunol. 66 (Suppl. 01) 121-126 1981;
    PubMedGoogle Scholar
  • 16 Camussi G, Tetta C, Coda R, Benveniste J. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus. Lab. Invest. 44: 241-251 1981;
    PubMedGoogle Scholar
  • 17 Camussi G, Bosio D, Sergoloni G, Tetta C, Vercellone A. Evidence for the involvement of the IgE-basophil-mastocyte system in human acute poststreptococcal glomerulonephritis. La Ricerca 8: 56-64 1978;
    PubMedGoogle Scholar
  • 18 Martini A, Levy M, Broyer M, Hirsch J.F, Benveniste J. Sensibilisation des basophiles envers le staphylocoque au cours d’une glomerulonéphrite secondaire à l’infection d’une déviation ventriculo-atriale. J. Urol. Néphrol. 84: 349-353 1978;
    PubMedGoogle Scholar
  • 19 George C.R.P, Slichter S.C, Qudracci L.J, Striker G.E, Harker L.A. A kinetic evaluation of hemostasis in renal disease. New Engl. J. Med. 293: 1111-1115 1974;
    PubMedGoogle Scholar
  • 20 Clark W.F, Lewis M.L, Cameron J.S, Parsons V. Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. Clin. Sci. Mol. Med. 49: 247-252 1975;
    PubMedGoogle Scholar
  • 21 Parbtani A, Frampton G, Cameron J.S. Measurements of platelet release substances in glomerulonephritis. A comparison of beta-thromboglobulin (BTG), platelet factor 4 (PF4) and serotonin assays. Thromb. Res. 19: 177-189 1980;
    CrossrefPubMedGoogle Scholar
  • 22 Woo K.T, Whitworth J.A, Kincaid-Smith P. Effect of antiplatelet agents on circulating platelet aggregates in patient with glomerulonephritis. Thromb. Res. 20: 663-668 1980;
    CrossrefPubMedGoogle Scholar
  • 23 Andrassy K, Ritz E, Mauerhoff T, Bommer J. What is the evidence for activated coagulation in glomerulonephritis?. Amer. J. Nephrol. 2: 293-300 1982;
    CrossrefPubMedGoogle Scholar
  • 24 Duffy J.L, Cinque T, Grishman E, Churg J. Intraglomerular fibrin platelet aggregation and subendothelial deposits in lipoid nephrosis. J. Clin. Invest. 49: 251-258 1970;
    CrossrefPubMedGoogle Scholar
  • 25 Parbtani A, Frampton G, Cameron J.S. Platelet and plasma serotonin concentrations in glomerulonephritis, II. Clin. Nephrol. 14: 112-123 1980;
    PubMedGoogle Scholar
  • 26 Parbtani A, Frampton G, Kasai N, Yewdall V, Cameron J.S. Platelet and plasma serotonin concentrations in glomerulonephritis. III. The nephritis of systemic lupus erythematosus. Clin. Nephrol. 14: 164-172 1980;
    PubMedGoogle Scholar
  • 27 Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Clin. Nephrol. 17: 24-30 1982;
    PubMedGoogle Scholar
  • 28 Richman A.V, Kashic G. Endothelial and platelet reactions in the idiopathic nephrotic syndrome. Hum.. Pathol. 13: 548-553 1982;
    CrossrefPubMedGoogle Scholar
  • 29 Miller K, Dresner I.G, Michael A.F. Localization of platelet antigens in human kidney disease. Kidney Int. 18: 472-479 1980;
    CrossrefPubMedGoogle Scholar
  • 30 Duffus P, Parbtani A, Frampton G, Cameron J.S. Intraglomerular localisation of platelet-related antigens, platelet factor 4 and β-thromboglobulin in glomerulonephritis. Clin. Nephrol. 18: 298-302 1982;
    PubMedGoogle Scholar
  • 31 Kasai N, Parbtani A, Yewdall V, Shepherd P, Verroust P, Cameron J.S. Platelet-aggregating immune complexes in glomerulonephritis. Clin. Exp. Immunol. 43: 64-72 1981;
    PubMedGoogle Scholar
  • 32 Lavelle K.J, Noseman A.M. The influence of selective thrombocytopenia on immune complex glomerulonephritis. J. Lab. Clin. Med. 192: 737-749 1978;
    PubMedGoogle Scholar
  • 33 Lavelle K.J, Ransdell B.A, Kleit S.A. The influence of selective thrombocytopenia on nephrotoxic nephritis. J. Lab. Clin. Med. 87: 967-975 1976;
    PubMedGoogle Scholar
  • 34 Sindrey M, Marshall T.L, Naish P. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin. Exp. Immunol. 36: 90-96 1979;
    PubMedGoogle Scholar
  • 35 Cochrane C.G. Mechanisms involved in the deposition of immune complexes in tissues. J. exp. med. 134: 75s-89s 1971;
    PubMedGoogle Scholar
  • 36 Kniker W.T. Modulation of the inflammatory response in vivo prevention of amelioration of immune complex disease. In: Lepow I.H, Ward P.A. (Eds.) Inflammation mechanisms and Control. Academic Press; New York: 1972: 335-367.
    Google Scholar
  • 37 Bolton W.K, Spargo B.A, Lewis E.J. Chronic autologous immune complex glomerulopathy: effect of Cyproheptadine. J. Lab. Clin. Med. 83: 695-704 1974;
    PubMedGoogle Scholar
  • 38 Ida T, Tomura S, Sakurai S, Chida Y, Takeuchi J. The role of platelets in BSA nephritis. Abstract No. EX 013. Abstr. 9th Congr. Int. Soc. Nephrol. Athens. 214 1981
    PubMedGoogle Scholar
  • 39 Nagase M, Honda N. Possible mechanisms of antiproteinuric effect of dipyridamole in nephrotic rats induced by aminonu-cleoside. 8th Int. Congr. Pharmacol., Tokyo, (Abstr.) 1981
    PubMedGoogle Scholar
  • 40 Tojo S, Narita M, Koyama A, Sano M, Suzuki H, Tsuchiya T, Tsuchida H, Yamamoto S, Shishido H. Dipyridamole therapy in the nephrotic syndrome. Contrib. Nephrol. 9: 111-127 1978;
    PubMedGoogle Scholar
  • 41 Cameron J.S. The treatment of severe glomerulonephritis with combined immunosuppression and anticoagulation. Proc. Sixth Int. Congr. Nephrol., Montreal. Karger, Basel 1981, pp. 419-424.
    PubMedGoogle Scholar
  • 42 Futrakul P, Poshyachinda M, Mitra-kul C. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Clin. Nephrol. 10: 180-186 1978;
    PubMedGoogle Scholar
  • 43 Donadio J.V, Anderson C.F, Mitchell J.C, Holley K.E, Ilstrup D.M, Fuster V. Membranoproliferative glomerulonephritis (MPGN): a prospective clinical trial of platelet inhibitor therapy. Am. Soc. Nephrol. (Abstr.), Kidney Int. 23: 28A 1982;
    PubMedGoogle Scholar
  • 44 Hugues S. Accolement des plaquettes aux structures conjonctives perivasculaires. Thromb. Diath. Haemorrh. 8: 241-245 1962;
    PubMedGoogle Scholar
  • 45 Barnec M, Bailey A, Gordon J, Mclntyre D. Platelet aggregation to basement membrane-associated collagens. Thromb. Res. 18: 375-388 1980;
    CrossrefPubMedGoogle Scholar
  • 46 Vargaftig B.B, Chignard M, Benveniste J. Present concepts on the mechanisms of platelet aggregation. Biochem. Pharmacol. 30: 263-271 1981;
    CrossrefPubMedGoogle Scholar
  • 47 Bertele V, Cerletti C, Schiepatti A, di Minno G, deGaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet I: 1057-1058 1981;
    PubMedGoogle Scholar